Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients

The relevance of blood-based assays to monitor minimal residual disease (MRD) in non-metastatic prostate cancer (PCa) remains unclear. Proving that clinically relevant circulating tumor cells (CTCs) can be detected with available technologies could address this. This study aimed to improve CTC detec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Kuske, Andra, Gorges, Tobias M., Tennstedt, Pierre, Tiebel, Anne-Kathrin, Pompe, Raisa, Preißer, Felix, Prues, Sandra, Mazel, Martine, Markou, Athina, Lianidou, Evi, Peine, Sven, Alix-Panabières, Catherine, Riethdorf, Sabine, Beyer, Burkhard, Schlomm, Thorsten, Pantel, Klaus
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5175156/
https://ncbi.nlm.nih.gov/pubmed/28000772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep39736
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados